Tag(s):
Third Circuit upholds Amgen dismissal
Wednesday, 15 June 2011
A US appeals court has upheld the dismissal of a potential class action antitrust lawsuit alleging that drug maker Amgen illegally tied together two related types of drugs to solidify its market power and shut out competition.



